Register for free to listen to this article
Listen with Speechify
0:00
2:00
BELMONT, Mass. & OSLO, Norway—In February, Radiant Sage LLC, a provider of on-demand clinical trial imaging infrastructure solutions and services, announced that it has expanded its operations into Europe through its partnership with Clearpoint Image Review Center (CIRC). Based in Oslo, Norway, CIRC is an imaging contract research organization (CRO) that provides sponsors with extensive medical, operational and image management expertise in support of clinical trials.
 
CIRC will provide the facility and staffing resources for program management-based support for clinical studies in both the European Union and the United States. They will also offer a wide range of services, including audit support, document development and reader logistics to clinical study sponsor communications, site support and metrics reporting. In addition, CIRC will be able to leverage Radiant Sage's technology, staff and resources to support clients' clinical research studies.
 
Jeffrey Bowden, Radiant Sage’s chief operating officer explained: “This teaming partnership represents an evolution in the industry, which is being driven by both advances in technology and the needs of clinical trial sponsors. Products like our Corelab-In-A-Box are virtually eliminating the need to have large laboratories of expensive imaging technology centrally maintained to process images and organize data for blinded reads. Now, trial sponsors can make much better use of regionally defined experts in a similar approach to that used in the CRO industry where medical monitors, program managers and clinical research associates are now decentralized and regionally located, providing a higher level of service to sponsors and clinical sites. The same can be done within the core lab industry, which is why this partnership with CIRC is an evolutionary step and will provide clinical trial sponsors with superior services, expertise and experience.”
 
“Our clients are located throughout the world, and having a partner in Europe will help us to better serve clinical trial sponsors with exceptionally experienced and regionally located staffing,” said Venkatesan Thangaraj, Radiant Sage’s CEO. “This partnership is a win-win for both companies, as well as our clients. We have complementary services and enable each other to expand our geographic footprints.”

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue